Plain-English translation of NCT06724653 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Heart Failure research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether patients with heart failure whose hearts have recovered can safely reduce or stop some of their medications. If your heart has improved significantly — going from weakened function to normal or near-normal — researchers want to know if you can take lower doses of drugs like RAS blockers or beta blockers without losing that improvement. The study will randomly assign you to either gradually reduce one type of medication or keep taking your current doses while your heart function is monitored.
Once a heart failure patient's heart function recovers, doctors aren't sure whether patients still need to take all their medications at full strength. This trial exists to find out if the medication can be safely reduced in people whose hearts have healed, which could reduce side effects and costs while maintaining their recovery.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to either a group that gradually reduces one type of heart failure medication or a group that continues taking all medications at current doses. Over the next 1 to 3 months, you'll have heart ultrasounds and blood tests to monitor your heart function and ensure your recovery is holding up. The study team will watch closely to make sure any medication changes are safe for you.
AI-generated summary from trial data · Jun 11, 2026 · Not medical advice
South Korea